SEER Q4 2025 Earnings — Seer, Inc. Revenue & Financial Results | Market Cap Arena

SEERSeer, Inc.

$101M

Q4 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$4M+6.4% YoY

Gross Profit

$2M52.0% margin

Operating Income

-$17M-413.8% margin

Net Income

-$16M-380.7% margin

EPS (Diluted)

$-0.29

QoQ Revenue Growth

+1.9%

Cash Flow

Operating Cash Flow

-$11M

Free Cash Flow

-$11M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$296M

Total Liabilities

$37M

Stockholders' Equity

$259M

Cash & Equivalents

$47M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$4M	$4M	+6.4%
Gross Profit	$2M	$366,000	+496.4%
Operating Income	-$17M	-$24M	+26.1%
Net Income	-$16M	-$22M	+26.4%